{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:25:17Z","timestamp":1780046717416,"version":"3.53.1"},"reference-count":19,"publisher":"Georg Thieme Verlag KG","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1055\/s-0044-1788997","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T22:59:54Z","timestamp":1722985194000},"page":"1024-1026","source":"Crossref","is-referenced-by-count":4,"title":["Open Issues in the Choice and Management of Direct Oral Anticoagulants in Patients with Cancer-Related Venous Thromboembolism"],"prefix":"10.1055","volume":"124","author":[{"given":"Daniele","family":"Pastori","sequence":"additional","affiliation":[{"name":"Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gualtiero","family":"Palareti","sequence":"additional","affiliation":[{"name":"Fondazione Arianna Anticoagulazione, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,8,6]]},"reference":[{"issue":"11","key":"ref1","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1055\/a-2316-5269","article-title":"Edoxaban, rivaroxaban, or apixaban for cancer-associated venous thromboembolism in the real world: insights from the COMMAND VTE Registry-2","volume":"124","author":"D Sueta","year":"2024","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1055\/s-0040-1708481","article-title":"A meta-analysis of case fatality rates of recurrent venous thromboembolism and major bleeding in patients with cancer","volume":"120","author":"A Abdulla","year":"2020","journal-title":"Thromb Haemost"},{"issue":"11","key":"ref3","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1055\/a-2299-4758","article-title":"Machine learning-based predictive models for patients with venous thromboembolism: a systematic review","volume":"124","author":"V Danilatou","year":"2024","journal-title":"Thromb Haemost"},{"issue":"05","key":"ref4","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1055\/s-0040-1720976","article-title":"Risk factors for central venous access device-related thrombosis in hospitalized children: a systematic review and meta-analysis","volume":"121","author":"L Tian","year":"2021","journal-title":"Thromb Haemost"},{"issue":"10","key":"ref5","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1055\/s-0042-1749185","article-title":"Risk of thromboembolic events in cancer patients treated with immune checkpoint inhibitors: a meta-analysis of randomized controlled trials","volume":"122","author":"Z Ma","year":"2022","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref6","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1055\/a-1647-9896","article-title":"Extended anticoagulant treatment with full- or reduced-dose apixaban in patients with cancer-associated venous thromboembolism: rationale and design of the API-CAT study","volume":"122","author":"I Mah\u00e9","year":"2022","journal-title":"Thromb Haemost"},{"issue":"12","key":"ref7","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1055\/a-1886-5991","article-title":"Treatment and bleeding complications of cancer-associated venous thromboembolism: a Korean population-based study","volume":"122","author":"S A Kim","year":"2022","journal-title":"Thromb Haemost"},{"issue":"07","key":"ref8","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1056\/NEJMoa1711948","article-title":"Edoxaban for the treatment of cancer-associated venous thromboembolism","volume":"378","author":"G E Raskob","year":"2018","journal-title":"N Engl J Med"},{"issue":"17","key":"ref9","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJMoa1915103","article-title":"Apixaban for the treatment of venous thromboembolism associated with cancer","volume":"382","author":"G Agnelli","year":"2020","journal-title":"N Engl J Med"},{"issue":"09","key":"ref10","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1055\/a-2269-1123","article-title":"Racial differences in bleeding risk: an ecological epidemiological study comparing Korea and United Kingdom subjects","volume":"124","author":"D S Kang","year":"2024","journal-title":"Thromb Haemost"},{"issue":"07","key":"ref11","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1055\/a-1792-7720","article-title":"Growth differentiation factor-15, high-sensitivity cardiac troponin T, and N-terminal pro-B-type natriuretic peptide for predicting risk of venous thromboembolism in ambulatory cancer patients receiving chemotherapy","volume":"122","author":"D C Roy","year":"2022","journal-title":"Thromb Haemost"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1055\/s-0042-1759879","article-title":"Increased cancer risk in patients with kidney disease and venous thromboembolism: a population-based cohort study","volume":"123","author":"J R\u00f8nnow Sand","year":"2023","journal-title":"Thromb Haemost"},{"issue":"11","key":"ref13","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1055\/s-0043-1769609","article-title":"Risk factors of venous thromboembolic disease in cancer patients treated with immune checkpoint inhibitor","volume":"123","author":"J D le S\u00e8ve","year":"2023","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref14","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)","volume":"41","author":"S V Konstantinides","year":"2020","journal-title":"Eur Heart J"},{"issue":"06","key":"ref15","doi-asserted-by":"crossref","first-page":"e545","DOI":"10.1016\/j.chest.2021.07.055","article-title":"Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report","volume":"160","author":"S M Stevens","year":"2021","journal-title":"Chest"},{"issue":"07","key":"ref16","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1055\/s-0043-1778642","article-title":"Early time courses of recurrent venous thromboembolism and bleeding during apixaban or dalteparin therapy for patients with cancer","volume":"124","author":"A T Cohen","year":"2024","journal-title":"Thromb Haemost"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1055\/a-2259-0662","article-title":"Comparison of clinical outcomes in patients with active cancer receiving rivaroxaban or low-molecular-weight heparin: the OSCAR-UK study","author":"A T Cohen","year":"2024","journal-title":"Thromb Haemost"},{"issue":"10","key":"ref18","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1182\/blood-2013-04-460121","article-title":"Epidemiology of cancer-associated venous thrombosis","volume":"122","author":"J F Timp","year":"2013","journal-title":"Blood"},{"issue":"04","key":"ref19","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.3390\/ijms24043169","article-title":"A comprehensive review of risk factors for venous thromboembolism: from epidemiology to pathophysiology","volume":"24","author":"D Pastori","year":"2023","journal-title":"Int J Mol Sci"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0044-1788997.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T16:26:07Z","timestamp":1730823967000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0044-1788997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,6]]},"references-count":19,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,10,28]]},"published-print":{"date-parts":[[2024,11]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0044-1788997","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"value":"0340-6245","type":"print"},{"value":"2567-689X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,6]]}}}